Noradrenalin can regulate progression of Alzheimer`s disease

Bonn, 15th March 2010 Noradrenalin reduces inflammation in the nervous system and regulates the removal of β-Amyloid in microglial cells, this what Professor Michael Heneka and colleagues of the “Deutschen Zentrum für Neurodegenerative Erkrankungen” and the University of Bonn show. With this publication, the scientist show a new therapeutic approach to delay the onset of the Alzheimer`s disease. Inflammations and the aggregation of β-Amyloid are thought to be the causes of the disease. The scientists publish their results in the magazine “Proceedings of the National Academy of Sciences“ (online publication).


Prof. Dr. Michael T. Heneka
Deutsches Zentrum für Neurodegenerative Erkrankungen e. V. (DZNE)
Universität Bonn
+49 (0228) 287 13092

Sonja Jülich-Abbas
Deutsches Zentrum für Neurodegenerative Erkrankungen e. V. (DZNE)
DZNE Public Relations
+49 (228) 30899-225
+49 (172) 2838930

Welcome to our website, here you can inform yourself basically cookie-free.

We would be pleased if you would allow a cookie to be set for analysis purposes in order to optimise our provided information. All data are pseudonymous and are only used by the DZNE. We deliberately avoid third-party cookies. You can deselect this setting at any time here.

Your browser allows the setting of cookies: